Inhaled corticosteroids (ICS) are the mainstay of treatment for asthma, but their role in
chronic obstructive pulmonary disease (COPD) is debated. Recent randomised controlled …

Phosphodiesterase (PDE) 4 inhibitors prevent the metabolism of cyclic adenosine
monophosphate, thereby reducing inflammation. Inhaled PDE4 inhibitors aim to restrict …

The development of molecules embedding two distinct pharmacophores acting as
muscarinic antagonists and β2 agonists (MABAs) promises to be an excellent opportunity to …

Background: Chronic obstructive pulmonary disease (COPD) inflammatory endotypes are
associated with different airway microbiomes. We used quantitative polymerase chain …

Background. The effective-component compatibility of Bufei Yishen formula III (ECC-BYF III)
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …

Chronic obstructive pulmonary disease (COPD) is a progressive disease that is certainly
preventable and treatable and is caused due to the continuous exposure to noxious …

Background. Chronic obstructive pulmonary disease (COPD) is becoming a major public
health burden worldwide. It is urgent to explore more effective and safer treatment strategy …

Chronic obstructive pulmonary disease (COPD) is a complex disease, and its pathogenesis
is influenced by genetic factors. This study aimed to evaluate the role of IL5RA genetic …

Chronic obstructive pulmonary disease (COPD) is a highly prevalent condition associated
with smoking and is predicted to become a leading cause of death in the current decade [1] …

Background Chronic obstructive pulmonary disease (COPD), a chronic inflammatory lung
disease, is a leading cause of morbidity and mortality worldwide. Prolonged cigarette …